Market Research Logo

US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2020)

US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2020)

Scope of the Report

The report entitled “US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2021)”, provides analysis of the US lymphedema market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the US Pneumatic Compression Device (PCD) market, by value, by device adoption, by players, etc.

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US lymphedema market has also been forecasted for the years 2016-2020, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.

Tactile is the only company providing the Advanced PC device, named Flexitouch. The other key companies in the market are Bio Compression System, Wright Therapy Products and Lympha Press, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Company Coverage

Tactile Medical
Bio Compression System
Lympha Press (Mego Afek)
Wright Therapy Products (BSN Medical)

Executive Summary

Lymphedema is when excess lymphatic fluid gets collected in the tissues under the skin, which causes swelling. Generally, lymphedema occurs due to the damage or removal of lymph nodes, as a part of cancer surgery.

Lymphedema can be divided into 4 stages, based on the swelling it causes and its severity. There are two types of lymphedema: Primary Lymphedema and Secondary Lymphedema. Primary lymphedema is detected in the children and it is generally the result of an error in the development of the lymphatic system. Secondary lymphedema represents more than 99% of the total cases. It occurs due to the cancer treatment or surgery, resulting in the removal of lymph nodes.

There are many options of treatment of lymphedema available today. These can be used as a single option, and/or in combinations. Treatment of Lymphedema includes: Controlled Compression Therapy, Manual Lymph Drainage (MLD), Complete Decongestive Therapy (CDT) and Pneumatic Compression (PC). PCD are the devices which deliver intermittent pressure through varying inflation and deflation chambers, to move the lymph fluid from extremity and to avoid the adverse consequences of uncontrolled lymphedema.

The US lymphedema market is expected to increase at a significant growth rate during the forecasted period (2016-2021). The US lymphedema market is supported by various growth drivers, such as increasing per capita healthcare expenditure in the US, sever long term effects of non treatment of lymphedema, increasing cancer cases every year, etc. Yet, the market faces certain challenges, such as, reimbursement issues, low awareness, etc.


1. Executive Summary
2. Introduction
2.1 Lymphedema: An Overview
Table A: Lymphedema Classification Scale
2.2 Types of Lymphedema
Table 1: Type of Lymphedema
2.3 Treatment of Lymphedema
Table 2: Treatment of Lymphedema
3. Market Analysis
3.1 US Lymphedema Market: An Analysis
3.1.1 US Lymphedema Market by Number of Patients
Table 3: Total US Population; 2015-2020 (Million)
Table 4: US Lymphedema Market by Number of Patients and Penetration; 2015-2020
3.1.2 US Lymphedema Market by Number of Patients Diagnosed
Table 5: US Lymphedema Market by Number of Patients Diagnosed; 2015-2020
3.1.3 US Lymphedema Market by Diagnosed Patients Severity
Table 6: US Lymphedema Market by Number of Diagnosed Patients Severity; 2015-2020
3.1.4 US Lymphedema Market by Total Addressable Market (TAM)
Table 7: US Lymphedema Market by Total Addressable Market (TAM); 2015-2020 (US$ Million)
3.2 US Lymphedema Market: Patient Analysis
3.2.1 US Lymphedema Patients by Causes
Table 8: US Lymphedema Patients by Causes
3.2.2 US Lymphedema Patients by Demographics
Table 9: US Lymphedema Patients by Gender
Table 10: US Lymphedema Patients by Age Group
3.3 US Lymphedema Pneumatic Compression Device (PCD) Market: An Analysis
3.3.1 US PCD Market by Case Adoption
Table 11: US PCD Market by Case Adoption; 2016-2020
3.3.2 US PCD Market by ASP
Table 12: US PCD Market by ASP; 2015-2020
3.3.3 US PCD Market by Value
Table 13: US PCD Market by Value; 2016-2020 (US$ Million)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Per Capita Healthcare Expenditure in the US
Table 14: US Per Capita Healthcare Expenditure; 2007-2014 (US$)
4.1.2 Increasing Obese Population
Table 15: Percentage of Obese Population (Above 20 Years) in the US; 1999-2014
4.1.3 Increasing Cancer Cases
Table 16: New Cancer Cases in the US; 2015
4.1.4 Long Term Effects Increase the Demand for PCD Devices
4.2 Challenges
4.2.1 Reimbursement Issues
4.2.2 Improvement in Treatment of Cancer
4.2.3 Low Awareness
4.3 Market Trends
4.3.1 At-home Treatment
4.3.2 Cost Effectiveness of Flexitouch
4.3.3 Effects of Exercise
4.3.4 Evolving Treatment Options for Lymphedema
5. Competitive Landscape
5.1 US PCD Market Share by Players
Table 17: US PCD Market Share by Players; 2016-2020
5.2 US PCD Comparison by Players
Table B: Pneumatic Compression Pump/ Device Comparison by Players
6. Company Profiling
6.1 Tactile Systems Technology
6.1.1 Business Overview
6.1.2 Financial Overview
Table 18: Tactile Revenue; 2013-2016E (US$ Million)
Table 19: Tactile Revenue by Segments; 2015
6.1.3 Business Strategy
6.2 Bio Compression System
6.2.1 Business Overview
6.2.2 Business Strategy
6.3 Lympha Press (Mego Afek)
6.3.1 Business Overview
6.3.2 Business Strategy
6.4 Wright Therapy Products, Inc. (BSN Medical)
6.4.1 Business Overview
6.4.2 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report